FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Alfredo Rivas

Research Profile

Living Beings

Anatomy

Tumor Cell Line

Chemicals & Drugs

Physiology

Disorders

Genes & Molecular Sequences

Genes, bcl-1

Co-author Network

Publications

TOP 3
Mercedes Tkach; Wendy Beguelin; Ernesto Gil Deza; María Celeste Díaz Flaqué; Patricia V Elizalde; Felipe G Gercovich; Pablo Guzmán; Esteban Maronna; María Florencia Mercogliano; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Martin Alfredo Rivas; Roxana Schillaci; Leandro Venturutti; Tim Hui-Ming Huang; Yi-Wen Huang; Patricia V Elizalde
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Alfredo Rivas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mercedes Tkach; Wendy Beguelin; Ernesto Gil Deza; María Celeste Díaz Flaqué; Patricia V Elizalde; Felipe G Gercovich; Pablo Guzmán; Esteban Maronna; María Florencia Mercogliano; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Endocrine-related cancer 2013;20(2):197-212.
2012: Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(3):1162-72.
2012: Martin Alfredo Rivas; Roxana Schillaci; Leandro Venturutti; Tim Hui-Ming Huang; Yi-Wen Huang; Patricia V Elizalde
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Breast cancer research : BCR 2012;14(3):R77.
2012: Tiphanie Durfort; Mariya I Meschaninova; Alya G Venyaminova; Martin Alfredo Rivas; Roxana Schillaci; Patricia V Elizalde; Mercedes Tkach; Jean-Christophe François
Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
PloS one 2012;7(1):e29213.
2011: Cecilia J Proietti; Wendy Béguelin; María Celeste Díaz Flaqué; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Steroids 2011;76(4):381-92.
2010: Wendy Béguelin; María Celeste Díaz Flaqué; Cecilia J Proietti; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Cinthia Rosemblit; Johanna M Tocci; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.
Molecular and cellular biology 2010;30(23):5456-72.
2010: Martin Alfredo Rivas; Mercedes Tkach; Wendy Beguelin; Cecilia J Proietti; Cinthia Rosemblit; Eduardo H Charreau; Patricia V Elizalde; Roxana Schillaci
Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Breast cancer research and treatment 2010;122(1):111-24.
2009: Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Martin Alfredo Rivas; María Celeste Díaz Flaqué; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.
Molecular and cellular biology 2009;29(5):1249-65.
2008: Martin Alfredo Rivas; Romina Carnevale; Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Mariana Salatino; Eduardo H Charreau; Isabel Frahm; Sandra Sapia; Peter Brouckaert; Patricia V Elizalde; Roxana Schillaci
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Experimental cell research 2008;314(3):509-29.
2006: Roxana Schillaci; Mariana Salatino; Juliana Cassataro; Cecilia J Proietti; Guillermo H Giambartolomei; Martin Alfredo Rivas; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3426-37.